B. Riley Wealth Advisors’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,625
Closed -$236K 1464
2023
Q2
$236K Buy
+11,625
New +$236K 0.01% 1261

Other funds holding ANAB

B. Riley Wealth Advisors's ANAB Position: Q3 2023 in Review

B. Riley Wealth Advisors sold out of AnaptysBio (ANAB) in Q3 2023, closing a stake of 11,625 shares — an estimated $236K sold.

B. Riley Wealth Advisors first reported a position in ANAB in Q2 2023 and held it in 1 quarter. The position peaked at $236K in Q2 2023. 116 funds tracked by Wall St. Rank hold ANAB as of Q3 2023.

  • B. Riley Wealth Advisors reported no remaining AnaptysBio position as of Q3 2023 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 11,625 AnaptysBio shares in Q3 2023, an estimated $236K.
  • B. Riley Wealth Advisors first reported a position in AnaptysBio in Q2 2023 and held it in 1 quarter.
  • B. Riley Wealth Advisors's AnaptysBio position peaked at $236K in Q2 2023.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2023, filed 1 Dec 2023.